KL and cancer: Downregulation of KLOTHO by different epigenetic mechanisms has been reported in several types of cancer, resulting in aberrations in FGF signaling, as well as disturbed insulin-like growth factor 1 receptor (IGF-1R) and the Wnt/β-catenin signaling pathway [33].